» Articles » PMID: 10623654

Isolation by Size of Epithelial Tumor Cells : a New Method for the Immunomorphological and Molecular Characterization of Circulatingtumor Cells

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2000 Jan 7
PMID 10623654
Citations 440
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a new assay, ISET (isolation by size of epithelial tumor cells), which allows the counting and the immunomorphological and molecular characterization of circulating tumor cells in patients with carcinoma, using peripheral blood sample volumes as small as 1 ml. Using this assay, epithelial tumor cells can be isolated individually by filtration because of their larger size when compared to peripheral blood leukocytes. ISET parameters were defined using peripheral blood spiked with tumor cell lines (HepG2, Hep3B, MCF-7, HeLa, and LNCaP). ISET can detect a single, micropipetted tumor cell, added to 1 ml of blood. We also demonstrate that fluorescence in situ hybridization can be used to perform chromosomal analyses on tumor cells collected using ISET. Polymerase chain reaction-based genetic analyses can be applied to ISET-isolated cells, and, as an example, we demonstrate homozygous p53 deletion in single Hep3B cells after filtration and laser microdissection. Finally, we provide evidence for the in vivo feasibility of ISET in patients with hepatocellular carcinoma undergoing tumor resection. ISET, but not reverse transcriptase-polymerase chain reaction, allowed analysis of cell morphology, counting of tumor cells, and demonstration of tumor microemboli spread into peripheral blood during surgery. Overall, ISET constitutes a novel approach that should open new perpectives in molecular medicine.

Citing Articles

Multimodal Framework in Lung Cancer Management: Integrating Liquid Biopsy with Traditional Diagnostic Techniques.

Qi W, Tian L, Xu J, Li Z, Wang T Cancer Manag Res. 2025; 17:461-481.

PMID: 40060704 PMC: 11889406. DOI: 10.2147/CMAR.S506630.


Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer.

Meunier A, Hernandez-Castro J, Chahley N, Communal L, Kheireddine S, Koushki N Commun Med (Lond). 2025; 5(1):33.

PMID: 39900650 PMC: 11790846. DOI: 10.1038/s43856-024-00702-9.


Liquid biopsy for Renal Cell Carcinoma: A comprehensive review of techniques, applications, and future prospects.

Jani C, Abdallah N, Tan A, McKay R Kidney Cancer. 2025; 8(1):205-225.

PMID: 39886007 PMC: 11781563. DOI: 10.1177/24684570241303346.


Microfluidics engineering towards personalized oncology-a review.

Mishra S, Kumarasamy M In Vitro Model. 2025; 2(3-4):69-81.

PMID: 39871996 PMC: 11756504. DOI: 10.1007/s44164-023-00054-z.


Liquid Biopsy and Multidisciplinary Treatment for Esophageal Cancer.

Hoshi Y, Matsuda S, Takeuchi M, Kawakubo H, Kitagawa Y Cancers (Basel). 2025; 17(2).

PMID: 39857978 PMC: 11763614. DOI: 10.3390/cancers17020196.


References
1.
Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A . Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol. 1999; 112(2):171-8. DOI: 10.1093/ajcp/112.2.171. View

2.
Kohn E, Liotta L . Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 1995; 55(9):1856-62. View

3.
Cama C, Olsson C, Buttyan R, de Vries G, Wise G, Katz A . Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J Urol. 1997; 157(5):1748-51. View

4.
Wong L, Bateman W, Morris A, Fraser I . Detection of circulating tumour cells with the magnetic activated cell sorter. Br J Surg. 1995; 82(10):1333-7. DOI: 10.1002/bjs.1800821012. View

5.
Melchior S, Corey E, Ellis W, Ross A, Layton T, Oswin M . Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin Cancer Res. 1997; 3(2):249-56. View